Literature DB >> 14336784

TESTS FOR SYPHILIS. THE INCREASING INCIDENCE OF BIOLOGIC FALSE POSITIVE REACTIONS AS MEASURED BY TREPONEMA PALLIDUM IMMOBILIZATION.

C M CARPENTER, R A LECLAIR, R A BOAK, J N MILLER.   

Abstract

Analysis of data obtained in 25,787 Treponema pallidum immobilization tests in a ten-year period showed an increase in the incidence of biologic false positive (BFP) reactions for syphilis, and a decrease in the incidence of reactive TPI tests. The percentage of BFP tests increased from 54.2 per cent in 1953 to 70.7 per cent in 1962. Reaction to a standard serologic test for syphilis (STS) indicates only that the patient may have syphilis. A subsequent non-reactive TPI test remains the best procedure for ruling out a diagnosis of syphilis. Thus the clinician should be made more aware of the fact that a biologic false positive reaction strongly implies the existence of another disease, the cause of which should be investigated.

Entities:  

Keywords:  STATISTICS; TREPONEMA IMMOBILIZATION TEST

Mesh:

Substances:

Year:  1965        PMID: 14336784      PMCID: PMC1516109     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  4 in total

1.  The relationship of brucella infection to biologic false positive tests for syphilis.

Authors:  C M CARPENTER; J N MILLER; R A BOAK; C L HEISKBLL
Journal:  Am J Med Sci       Date:  1961-02       Impact factor: 2.378

2.  Biologic false positive reactions for syphilis in pregnancy as determined by the Treponema pallidum immobilization test.

Authors:  R A BOAK; C M CARPENTER; J N MILLER; H E DRUSCH; J M CHAPMAN; G A HEIDBREDER
Journal:  Surg Gynecol Obstet       Date:  1955-12

3.  A simple medium for maintaining the viability of Treponema pallidum in the Treponema pallidum immobilization test.

Authors:  R A BOAK; J N MILLER
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1954-09

4.  The incidence and etiologic background of chronic biologic false-positive reactions in serologic tests for syphilis.

Authors:  J E MOORE; C F MOHR
Journal:  Ann Intern Med       Date:  1952-12       Impact factor: 25.391

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.